TQC2938 Injection

TQC2938 · Chia Tai Tianqing Pharmaceutical Group; Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQC2938 Injection, covering 2024-06-10 to 2024-06-10. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects [Phase 1]